Canada News

Canadian News and
Press Release Distribution Services
Home | Submit Press Release
Unlimited Press Release Distribution
Press release distribution service

News Media

Abitibi-Témiscamingue
Business Vancouver
Canoe-ca
Canada News Center
Daily Herald Tribune
Canada.Com
CTVNews
La Press
National Post
The Globe and Mail
The Province
The Star
The Gazette
Toronto Sun
Yahoo! Canada

Canada Business News and Press Releases

BioMS Medical to Participate in Bioindustry Session at BioPartnering North America

(EMAILWIRE.COM, February 07, 2009 ) Edmonton, Alberta - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Ms. Amanda Stadel, Investor Relations Manager, will present at a session hosted by BioAlberta, Alberta's life science industry association, as part of the 7th Annual BioPartnering North America Conference in Vancouver.

This workshop will profile activities within Alberta's world-class health and biotechnology institutes as well as showcase companies that are active in the region.

TITLE: "Need + Innovation = Opportunity...Alberta, Canada"

WHEN: Monday February 9th at 4:30pm (Pacific Time)

WHERE: Westin Bayshore Resort, Vancouver

About BioPartnering North America
BioPartnering North America brings together decision-makers from leading biotechnology, pharmaceutical and investment companies and features company presentations, partnering meetings and expert panels and workshops. For more information visit http://www.techvision.com/bpn/

About BioAlberta
BioAlberta is a private, not-for-profit industry association, representing Alberta's growing bioindustry. For more information visit http://www.bioalberta.com/index.asp

About BioMS Medical Corp.
BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, dirucotide, is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for Secondary Progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. In December 2007, BioMS entered into a licensing and development agreement granting Eli Lilly and Company exclusive worldwide rights to dirucotide in exchange for an $87 million upfront payment, milestone payments and escalating royalties on sales. For further information please visit our website at http://www.biomsmedical.com


This press release may contain forward-looking statements, which reflect the Corporation's current expectation regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Corporation's ongoing quarterly and annual reporting. Certain of the assumptions made in preparing forward-looking statements include but are not limited to the following: that dirucotide ( MBP8298) will continue to demonstrate a satisfactory safety profile in ongoing and future clinical trials; and that BioMS Medical Corp. will complete the respective clinical trials within the timelines communicated in this release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.




Visit BioMS Medical Corporation Website: www.biomsmedical.com


---------------------------------

The Information in a Stockgroup Media Inc. Stockhouse News Hotline is A PAID ADVERTISEMENT and is for the viewers information only. BioMS Medical Corporation has paid a fee not exceeding $2500.00 in cash or stock to have their corporate information featured. The corporate information is purely and solely the responsibility of BioMS Medical Corporation and it is neither commented upon, researched, or in any manner the responsibility of Stockgroup Media Inc, whose only function is as a supplier of media facilities. Any information provided by the advertisers of Stockgroup Media Inc., through its media services, is not to be construed as a recommendation or suggestion or offerto buy or sell securities, but is provided purely as an informational media service. Stockgroup Media Inc. makes no warranties or undertakings as to the accuracy or completeness of this information. All due diligence should be done by the reader or their financial advisor. Investing in securities is speculative and carries risk. Persons who wish to buy or sell securities should only do so in consultation with their registered securities advisers.



###

This press release was issued through GroupWeb EmailWire.Com. For more information on unlimited SEO press release distribution for $99/month, go to http://www.emailwire.com


BioMS Medical Corp
Ryan Giese
780-413-7152
rgiese@biomsmedical.com


Canada News by Regions
  • Atlantic Canada
  • Calgary
  • Edmonton
  • Halifax
  • Montreal
  • Ottawa
  • Quebec
  • Toronto
  • Vancouver
  • Winnipeg


  • 
    
    
    

    Meeting and Travel
    We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Meetings & Travel resource center today to browse our selection of 600+ complimentary Meetings & Travel magazines, white papers, webinars, podcasts, and more. Get popular titles including:

    Group Tour Magazine
    Event Design
    Insite from Leisure Group Travel

    No credit cards, coupons, or promo codes required. Try it today!

    EmailWire.com - Press release service
    Press release distribution service

    For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com.
    Copyright 2009 GroupWeb Media LLC

    GroupWeb Media Network
    AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
    | InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
    I-Canada-News.com - I-Canada-News.Com is a news service of GroupWeb Media LLC